CA2973632C - Traitement de patients pediatriques souffrant de diabete sucre de type 2 avec du lixisenatide - Google Patents

Traitement de patients pediatriques souffrant de diabete sucre de type 2 avec du lixisenatide

Info

Publication number
CA2973632C
CA2973632C CA2973632A CA2973632A CA2973632C CA 2973632 C CA2973632 C CA 2973632C CA 2973632 A CA2973632 A CA 2973632A CA 2973632 A CA2973632 A CA 2973632A CA 2973632 C CA2973632 C CA 2973632C
Authority
CA
Canada
Prior art keywords
lixisenatide
treatment
patient
patients
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2973632A
Other languages
English (en)
Other versions
CA2973632A1 (fr
Inventor
Karin Bergmann
Agnes HINCELIN-MERY
Christelle Jan
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Priority claimed from PCT/EP2016/050804 external-priority patent/WO2016113404A1/fr
Publication of CA2973632A1 publication Critical patent/CA2973632A1/fr
Application granted granted Critical
Publication of CA2973632C publication Critical patent/CA2973632C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne le lixisénatide pour son utilisation en pédiatrie.
CA2973632A 2015-01-16 2016-01-15 Traitement de patients pediatriques souffrant de diabete sucre de type 2 avec du lixisenatide Active CA2973632C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15151488.2 2015-01-16
EP15151488 2015-01-16
PCT/EP2016/050804 WO2016113404A1 (fr) 2015-01-16 2016-01-15 Traitement de patients pédiatriques souffrant de diabète sucré de type 2 avec du lixisénatide

Publications (2)

Publication Number Publication Date
CA2973632A1 CA2973632A1 (fr) 2016-07-21
CA2973632C true CA2973632C (fr) 2025-08-12

Family

ID=

Similar Documents

Publication Publication Date Title
US20210187075A1 (en) Treatment of pediatric type 2 diabetes mellitus patients
US12186374B2 (en) Insulin glargine/lixisenatide fixed ratio formulation
Yaw Adu-Sarkodie Clinical management of diabetes mellitus in the older adult patient
CA2973632C (fr) Traitement de patients pediatriques souffrant de diabete sucre de type 2 avec du lixisenatide
HK1239556B (en) Treatment of pediatric type 2 diabetes mellitus patients with lixisenatide
NZ734595B2 (en) Treatment of pediatric type 2 diabetes mellitus patients with lixisenatide
BR112017015099B1 (pt) Uso de lixisenatida e/ou um sal farmaceuticamente aceitável da mesma para tratar pacientes pediátricos portadores de diabetes mellitus tipo 2
Harris CLINICAL PROTOCOL APPROVAL FORM
Long Diabetes Type 2: Nothing Sweet About It
Long Diabetes Type 2: Nothing Sweet About It (174)
EA039114B1 (ru) Применение композиции с постоянным соотношением инсулин гларгин/ликсисенатид для лечения сахарного диабета 2 типа